Merck & Co., Inc. (MRK) Backs Medivo in $15 Million in Series B Round
6/24/2013 8:20:16 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Medivo drums up $15 million in a Series B round led by Merck's Global Health Innovation fund. Merck (NYSE:MRK) led a $15 million Series B round for Medivo and its health data analytics platform. The round was also backed by repeat investors Safeguard Scientifics (NYSE:SFE) and MentorTech Ventures. Medivo has raised a total of $22 million to support its module for health analytics, which the company touts as HIPAA-compliant and user-friendly for physicians and patients.
Help employers find you! Check out all the jobs and post your resume.
comments powered by